Dealings involving intentional release

Limited and controlled release of sorghum genetically modified for asexual seed formation

Limited and controlled release of canola and Indian mustard genetically modified for altered oil content and herbicide tolerance

Limited and controlled release of wheat and barley genetically modified for yield enhancement and improved abiotic stress tolerance

Clinical trial with a genetically modified Bordetella pertussis for the prevention of whooping cough

Clinical trial with a genetically modified human adenovirus COVID-19 vaccine

Clinical trial with genetically modified E.coli to reduce antibiotic resistance

Commercial supply of a genetically modified COVID-19 vaccine

Clinical trial of a genetically modified Herpes virus for the treatment of cystic fibrosis

Commercial supply of a genetically modified COVID-19 vaccine

Clinical trial with a genetically modified Vaccinia virus based treatment for solid cancerous tumours

Commercial release of canola genetically modified for herbicide tolerance and a hybrid breeding system (MS11× RF3 and MS11 × RF3 × MON 88302)

Clinical trial of genetically modified human adenovirus for bladder cancer treatment

Limited and controlled release of white clover genetically modified for increased condensed tannins

Commercial release of canola (Brassica napus) genetically modified for herbicide tolerance and a hybrid breeding system (MS11)

Commercial supply of a genetically modified cholera vaccine, Vaxchora®

Commercial release of cotton genetically modified for herbicide tolerance (MON 88701)

Clinical trial of genetically modified influenza vaccine (H3N2 M2SR)

Limited and controlled release of microalgae genetically modified for increased production of fatty acids

Limited and controlled release of chickpea genetically modified for drought and other environmental stress tolerance

Limited and controlled release of wheat genetically modified for altered iron uptake, transport and bioavailability

Limited and controlled release of canola genetically modified for herbicide tolerance

Limited and controlled release of canola genetically modified for altered oil content and herbicide tolerance

Limited and controlled release of bread wheat and durum wheat genetically modified for enhanced rust disease resistance

A genetically modified respiratory syncytial virus (RSV) vaccine for use in clinical trials

Limited and controlled release of genetically modified insect-specific viruses as vaccines against Kunjin virus infection in farmed crocodiles

Commercial release of safflower genetically modified for high oleic acid composition

Commercial release of cotton genetically modified for insect resistance (COT102)

Limited and controlled release of buffalo grass genetically modified for herbicide tolerance and dwarf phenotype

Commercial release of canola genetically modified for omega-3 oil content (DHA canola)

Limited and controlled release of a GM vaccine for chickens, Vaxsafe^® ILT

Limited and controlled release of sorghum genetically modified for grain quality traits

Limited and controlled release of wheat and barley genetically modified for abiotic stress tolerance and yield improvement

Limited and controlled release of wheat genetically modified for disease resistance, drought tolerance, altered oil content and altered grain composition

Limited and controlled release of Indian mustard (Juncea canola) genetically modified for altered oil content

Commercial supply of Dengvaxia, an attenuated GM dengue vaccine

Limited and controlled release of cotton genetically modified for insect resistance and herbicide tolerance

Limited and controlled release of banana genetically modified for disease resistance

Commercial release of cotton genetically modified for insect resistance and herbicide tolerance (Bollgard^® 3 XtendFlex^™ and XtendFlex^™ cotton)

Clinical trial of live attenuated genetically modified influenza vaccines

Commercial release of cotton genetically modified for insect resistance and herbicide tolerance (GlyTol^® (BCS-GH002-5) and GlyTol TwinLink Plus^® (BCS-GH002-5 x BCS-GH004-7 x BCS-GH005-8 x SYN-IR102-7)

Clinical trial of a genetically modified virus for treatment of liver, kidney and prostate cancer

Commercial release of canola genetically modified for herbicide tolerance

Commercial release of canola genetically modified for dual herbicide tolerance and a hybrid breeding system

Commercial supply of attenuated GM influenza vaccines

Commercial supply of a tumour-selective genetically modified virus for cancer therapy

Commercial release of canola genetically modified for herbicide tolerance

Commercial release of genetically modified vaccine to protect chickens against pathogenic Escherichia coli

Commercial release of GM insect resistant and herbicide tolerant (COT102 x MON-15985 Bollgard^®III and COT102 x MON-15985 x MON 88913 Bollgard^®III x Roundup Ready Flex^®) cotton

Commercial release of herbicide tolerant (Roundup Ready Flex®MON88913) pima cotton in Australia

Commercial release of canola genetically modified for herbicide tolerance and a hybrid breeding system